Day 1 The World Orphan Drug Congress – Geneva

Europe’s leading forum for rare disease research & orphan drug advancement

The 3rd annual World Orphan Drug Congress is currently in session, providing a focus for discussions and engagement of the challenges facing the rare disease industry.

Karl Simpson, Owner  of Liftstream, offers insightful perspective as a participant at the World Orphan Drug Congress.

Day 1 The World Orphan Drug Congress – Geneva.

Advertisements